Peptides that form β-sheets on hydrophobic surfaces accelerate surface-induced insulin amyloidal aggregation  by Nault, Laurent et al.
FEBS Letters 587 (2013) 1281–1286journal homepage: www.FEBSLetters .orgPeptides that form b-sheets on hydrophobic surfaces accelerate
surface-induced insulin amyloidal aggregation0014-5793/$36.00  2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
http://dx.doi.org/10.1016/j.febslet.2012.11.036
⇑ Corresponding author.
E-mail address: marianne.weidenhaupt@grenoble-inp.fr (M. Weidenhaupt).Laurent Nault a, Charlotte Vendrely a, Yves Bréchet b, Franz Bruckert a, Marianne Weidenhaupt a,⇑
a Laboratoire des Matériaux et du Génie Physique, Phelma-Minatec, 3 Parvis Louis Néel CS 50257, F-38016 Grenoble Cedex 1, France
b Laboratoire de Science et Ingénierie des Matériaux et des Procédés, Phelma-Campus, 1130 rue de la Piscine, BP 75, F-38402 Saint-Martin d’Hères Cedex, France
a r t i c l e i n f o a b s t r a c tArticle history:
Received 12 July 2012
Revised 19 October 2012
Accepted 16 November 2012
Available online 16 March 2013
Edited by Jesus Avila
Keywords:
Material surface
Protein aggregation
Amyloidogenic peptide
InsulinInteractions between proteins and material or cellular surfaces are able to trigger protein aggrega-
tion in vitro and in vivo. The human insulin peptide segment LVEALYL is able to accelerate insulin
aggregation in the presence of hydrophobic surfaces. We show that this peptide needs to be previ-
ously adsorbed on a hydrophobic surface to induce insulin aggregation. Moreover, the study of dif-
ferent mutant peptides proves that its sequence is less important than the secondary structure of
the adsorbed peptide on the surface. Indeed, these pro-aggregative peptides act by providing stable
b-sheets to incoming insulin molecules, thereby accelerating insulin adsorption locally and facilitat-
ing the conformational changes required for insulin aggregation. Conversely, a peptide known to
form a-helices on hydrophobic surfaces delays insulin aggregation.
Structured summary of protein interactions:
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Many protein solutions are prone to aggregation in vitro. This is
particularly critical for therapeutic proteins because aggregate for-
mation decreases drug activity and can induce immunogenic reac-
tions when injected in patients. For instance, the most used protein
hormone, insulin, can be found in ﬁbrillar form at the site of fre-
quent insulin injections, which causes injection amyloidosis [1].
Moreover, the increasing prevalence of human diseases, character-
ized by the presence of large amounts of aggregated proteins, like
amyloidosis, Alzheimer’s, Parkinson’s and prion diseases, requires
mechanistic studies to understand protein aggregate formation.
The mechanism of protein ﬁbrillation is generally modeled in
three steps. (1) Conformational changes, due to defects in the cellu-
lar folding processes or due to an abnormal protein environment. (2)
Nucleation, during which the misfolded individual proteins are sta-
bilized, mostly by intermolecular interactions, which drives the for-
mation of oligomers. Such oligomers can then evolve into stable
nuclei. (3) Growth, during which the nuclei will grow upon binding
of other misfolded proteins, leading to the formation of large ﬁbrils.
In vivo, the growing step has a major impact on cell survival [2].
Human insulin (HI) has often been used as a model protein in
ﬁbrillation studies as it is a non-expensive protein which ﬁbrillatesrapidly in vitro, particularly at low pH, high temperature, high io-
nic strength and on hydrophobic surfaces [3–5]. In a preceding
study [6], we have shown that the presence of hydrophobic sur-
faces is essential for HI ﬁbrillation at pH 7.3 and 37 C. Such sur-
faces were assumed to induce the unfolding of HI monomers
adsorbed on them, but it appears that all three steps, including
nucleation and ﬁbril elongation also take place on the surface,
leading eventually to the release of mature ﬁbrils into solution.
Different studies show that the onset of aggregate nucleation
can be accelerated by the addition of peptides, which present a
pro-aggregative activity [7–10]. Such amyloidogenic peptides are
mostly hydrophobic, have beta-sheet conformation and are capa-
ble to ﬁbrillate by themselves. They are commonly derived from
protein sequences suspected to be involved in ﬁbrillation. In
2009, Ivanova et al. [11] showed that a 7 amino-acid peptide se-
quence, present in the B chain of native HI (LVEALYL, residues
B11–B17), was able, at sub-stoichiometric concentrations, to accel-
erate the nucleation step of human HI at pH 2.5. On the other hand,
it is known that surface hydrophobicity has an important effect on
the HI nucleation rate [12] and, given the hydrophobic nature of
this peptide, its amyloidogenic properties are likely to rely on its
interaction with hydrophobic surfaces. We recently demonstrated
that the LVEALYL peptide-driven acceleration of HI aggregation is
strictly dependent on the presence of hydrophobic surfaces [6].
In this study, we use mutants of the LVEALYL peptide together
with HI to investigate the effects of amino acid changes in this
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phobic surfaces and changes in peptide secondary structure. When
compared to previous studies measuring the effects of amyloido-
genic peptides on HI aggregation kinetics, we have introduced
two novel and important parameters: ﬁrst, the experiments are
done at physiological pH and, second, the effect of material surface
hydrophobicity is analyzed. Our work suggests that the LVEALYL
peptide and mutants thereof induce HI aggregation only if they
are previously adsorbed on the material surface. Moreover, it ap-
pears that their primary sequence is less important than their abil-
ity to stably adsorb in beta-structure on the surface.
2. Materials and methods
2.1. Chemicals
If not otherwise stated, all chemicals were purchased from Sig-
ma–Aldrich. Experiments were conducted in TBS (25 mM Tris–HCl,
pH 7.3, 125 mM NaCl and 2 mM MgCl2). HI (recombinant human
HI, expressed in yeast) solutions were prepared at 0.5 mg mL1
(86 lM). All solutions were ﬁltered (0.22 lm) before use. Peptides
were purchased from Genecust (Luxembourg) and a concentrated
stock solution was made at 860 lM in 20 mM NaOH.
2.2. Monitoring of aggregation kinetics
HI aggregation assays were conducted as 8 replicates in plastic
96-well microplates. Polystyrene (Greiner Bio-One, water contact
angle = 85 ± 4.7), or PEO-coated, (Corning 3651 microplate, water
contact angle = 3.5 ± 5.8) microplates were used. In ﬂuorescence
assays, black polystyrene microplates were used (Nunc Nunclon
D Surface). The plates were covered by plastic sheets, incubated
at 37 C and shaken at 1200 rpm (Heidolph Titramax, 1.5 mm
vibration orbit). Thioﬂavin T (ThT, 20 lM) ﬂuorescence was di-
rectly measured (kex = 450 nm, kem = 482 nm) in the wells [6].
2.3. Kinetic analysis
The aggregation kinetics proceeds in three phases: a lag phase,
where the signal is not statistically different from the baseline
(mean ± standard deviation), a linear growth phase and a plateau
phase. Experimentally, the lag time was deﬁned by the intercept
between the linear growth phase and the baseline. The growth rate
was deﬁned as the slope of the linear phase and the plateau as the
maximum value attained. The parameters were calculated on indi-
vidual kinetics corresponding to different replicates, and the given
statistics represent the average and the standard deviation for each
parameter.
2.4. Surface seeding using peptides
96-Well microplates were ﬁlled with peptides diluted at 8.6 lM
in TBS and incubated at 37 C, 1200 rpm for 10 min. Wells were
then washed once with TBS and ﬁlled with HI (86 lM) and incu-
bated at 37 C, 1200 rpm. HI aggregation kinetics was monitored
using ThT as described.
2.5. Quantiﬁcation of adsorbed protein
HI (86 lM) and/or peptide solutions (8.6 lM) were incubated in
96-well hydrophobic microplates in TBS for 30 min at 37 C,
1200 rpm. Wells were then washed with TBS and adsorbed pep-
tides and protein were desorbed using Sodium Dodecyl Sulfate
(5%) for 30 min at 37 C and 1200 rpm. The peptide and/or protein
concentrations were determined using the Bicinchoninic Assay
using Bovine Serum Albumin as a standard.2.6. Adsorption kinetics and infrared spectroscopy
Peptide and HI association and dissociation kinetics were stud-
ied on PEG- and C16-coated surfaces by SPRi as described in Nault
et al. [13]. The peptide conformation in solution and adsorbed on
hydrophobic surfaces was determined by FTIR transmission or
ATR-FTIR experiments, respectively [13].
2.7. Estimation of the hydrophobic contribution to the peptide binding
energy to hydrophobic surfaces
The hydrophobic contribution to the binding energy of 7 amino
acid long peptides with a hydrophobic surface was calculated for
two b-sheet conﬁgurations by the following formula:
DGconf1 ¼
X
1;3;5;7
DGi 
X
2;4;6
DGi ð1Þ
DGconf2 ¼
X
2;4;6
DGi 
X
1;3;5;7
DGi ð2Þ
DGsol ¼
X7
1
DGi ð3Þ
where DGi is the free transfer energy of the ith amino acid side
chain [14]. Conformation 1 and 2 correspond to the exposure of
even or odd amino acids to solvent, respectively. The third calcula-
tion corresponds to the hydrophobic contribution of the peptide
transfer energy into solution, with all amino acids exposed to the
solvent. This calculation does not consider the contribution of N-
and C-termini, which is identical for all peptides and conformations.
In the interpretation of the data, peptides are assumed to adopt the
conformation having the lowest interaction energy.
3. Results
3.1. The LVEALYL peptide accelerates HI aggregation kinetics when
bound to hydrophobic surfaces
As shownbefore [6], the LVEALYLpeptide acceleratesHI aggrega-
tion kinetics at pH7.3 and37 C, only in the presence of hydrophobic
surfaces (polystyrene) but not in the presence of PEG-coated sur-
faces preventing HI binding. The maximum effect is observed at a
peptide concentration of 8.6 lM, and the lag time is reduced by
66% on average (Table 1). We quantiﬁed the peptide adsorption on
microwells. Table 1 shows that 0.06 lg LVEALYL peptide remains
adsorbed on the hydrophobic surface after 30 min, corresponding
to 4.5% of the initial peptide amount. These minute amounts have
a dramatic effect onHI aggregation, as shownby the following seed-
ing experiment. Hydrophobic surfaces were pre-incubated for
10 min with peptide, washed and exposed to HI. Peptide pre-
adsorptiondecreases the lag-timeofHI aggregationby63% (Table1).
It is noteworthy that preincubating the surface with HI does not de-
crease the lag time (Table 1, line1).Moreover, supplying the solution
with 0.06 lg LVEALYL peptide, does not affect HI aggregation kinet-
ics. The pro-aggregative effect of the peptide is therefore due to the
adsorbed fraction on the surface. Upon adsorption, but not in solu-
tion, the LVEALYL peptide presents molecular features that strongly
accelerate HI binding and aggregation.
3.2. The pro-aggregative peptides LVEALYL and LVAELYL have a strong
effect on HI aggregation and adsorption kinetics
The strong effect of the LVEALYL peptide on HI aggregation
kinetics prompted us to study different peptide variants (Table 1).
All experiments were done at the same peptide (8.6 lM) and HI
(86 lM) concentrations. None of the peptides studied here
Table 1
Physico-chemical and pro-aggregative properties of different peptides. The binding energy corresponds to the hydrophobic contribution to the minimum interaction energy of the
peptide bound to the surface, calculated by Eqs. (1) or (2) (column 2). For the (LKKLLKL)2 peptide no interaction energy was calculated since this peptide is in a-helical
conﬁguration. Lag times were determined from the aggregation kinetics of a 1:10 peptide:protein mixture (column 3) and for a surface ﬁrst exposed to the indicated peptide
(8.6 lM) for 10 min, washed and then incubated with a fresh HI solution (86 lM) (column 4). Adsorption of peptides and peptide plus HI mixtures on hydrophobic surfaces
(2 cm2) was determined as described in Section 2 (column 5 and 6).
Peptide
sequence
Interaction energy
(kcal mol1)
Lag time of HI aggregation kinetics (h) Protein adsorbed on the surface after 30 min (lg)
8.6 lM peptide mixed with 86 lM
HI
After 10 min
seeding
8.6 lM peptide
alone
8.6 lM peptide mixed with 86 lM
HI
No peptide 4.4 ± 0.4 4.3 ± 0.4a 0.19 ± 0.01
LVEALYL 3.3 1.5 ± 0.2 1.7 ± 0.3 0.06 ± 0.01 0.21 ± 0.01
LVAELYL 16.3 0.4 ± 0.1 2.3 ± 0.3 0.10 ± 0.01 4.28 ± 0.10
LSASLSL 8.2 0.5 ± 0.1 2.5 ± 0.3 0.13 ± 0.01 0.25 ± 0.01
SVSASYS 1.1 2.0 ± 0.1 ND ND ND
LPEALYL 0.5 4.1 ± 0.3 ND ND ND
LVEPLYL 1.5 4.2 ± 0.2 ND ND ND
SVSPSYS 0.7 4.3 ± 0.4 ND ND ND
LVTALYL 6.1 0.5 ± 0.1 2.7 ± 0.3 0.16 ± 0.04 1.6 ± 0.2
LVATLYL 6.9 0.6 ± 0.1 1.8 ± 0.3 0.15 ± 0.02 0.5 ± 0.2
LVTPLYL 7.9 4.3 ± 0.1 ND ND ND
LVPTLYL 5.1 4.6 ± 0.1 ND ND ND
ISISISI 10.6 0.4 ± 0.1 ND ND ND
(LKKLLKL)2 ND >30 ND ND ND
a Seeding with 86 lM HI.
Fig. 1. SPRi sensorgrams of protein adsorption on hydrophobic surfaces. The
protein solutions (8.6 lM peptide, 86 lM HI or a mixture of 8.6 lM peptide and
86 lM HI) were injected at t = 0 min and the association kinetics were monitored
for 10 min (A) or 15 min (B). The surface was then washed with buffer and the
protein dissociation kinetics were monitored for 15 min (A) or 20 min (B). The
signal represented is the difference between the signal recorded on the C16-coated
side and the PEG-coated side of the prism. (A) SPRi curves obtained with peptides
LVEALYL and LSASLSL, (B) SPRi curves obtained with peptide LVAELYL.
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of PEG-coated surfaces, conﬁrming that the kinetic enhancement is
dependent on the presence of hydrophobic surfaces. Among the
peptides studied, the swapped peptide LVAELYL, where the third
and fourth amino acid are exchanged, exhibits a remarkably short
lag time (0.4 h). This peptide binds also strongly to hydrophobic
surfaces (0.1 lg) and pre-adsorption reduces the lag time of HI
aggregation down to 2.3 h (Table 1).
The binding kinetics of both peptides, alone and in combination
with HI, were studied by SPRi (Fig. 1A and B). As shown before [13],
HI alone binds speciﬁcally to hydrophobic surfaces, in a biphasic
manner. Fast, reversible binding is followed by a slower increase
of HI adsorption, resulting in the formation of a strongly bound
HI pool ([13] and Fig. 1). The LVEALYL and LVAELYL peptides alone
bind weakly to the hydrophobic surface (Fig. 1A and B). Mixing one
of the peptides with HI enhances protein adsorption on the hydro-
phobic surface but has no effect on HI adsorption on the hydro-
philic surface (Fig. 1A and B). More speciﬁcally, upon injection of
HI with either peptide, there is an increase of the fast association
component (ﬁrst minutes of Fig. 1A and B) and of the slow dissoci-
ation component of the SPRi signal (last 10 min of Fig. 1A and last
20 min of Fig. 1B), compared to HI alone. The addition of sub-stoi-
chiometric amounts of both peptides to HI therefore induces the
formation of strongly adsorbed HI on the hydrophobic surface. A
direct measurement of protein binding to microwell plastic sur-
faces conﬁrms this result (Table 1). In the presence of the swapped
peptide, the total protein bound is larger than in the presence of HI
or peptide alone. The wild-type peptide also enhances, but to a les-
ser extent, protein binding on the surface (Table 1).
3.3. The wild type and the swapped peptides adopt a b-sheet
conformation on hydrophobic surfaces
Infrared spectroscopy is sensitive to protein secondary struc-
ture in the amide I band and was used to analyze the conforma-
tional state of different peptides in solution (FTIR) or adsorbed
on hydrophobic surfaces (ATR-FTIR). Decomposing the band into
peaks shows that in solution, the wild type and swapped peptides
adopt mostly unstructured conformations (Fig. 2A and B, left pan-
els). Indeed, they present a major peak around 1645 cm1, indica-
tive of random coil conformation, which accounts for 37% and 32%
in the wildtype and swapped peptides’ solution spectra, respec-
tively (Table 1S). After 30 min adsorption on hydrophobic surfaces,the amide I band of both peptides changes and reveals prominent
peaks around 1694, 1680, 1664, 1648, 1633 and 1622 cm1 (Fig. 2A
and B, right panels). This indicates that the conformation of the ad-
sorbed wild type and swapped peptides consists predominantly of
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unstructured coil contribution consisting of 17 and 22%, respec-
tively (Table 1S).
3.4. Characterization of other amyloidogenic peptides: inﬂuence of
primary and secondary structure
In order to explain the peptide effect on the HI aggregation rate,
a simple model was built, assuming that amyloidogenic peptides
adopt a b-sheet conformation parallel to the material surface, sta-
bilized by intermolecular hydrogen bonds and side chain interac-
tions with the hydrophobic surface on one side, and the solvent
on the other side. Amino acid side chains indeed alternatively point
to one side or the other of a b-strand. For a 7 amino acid long pep-
tide, two such conformations exist, with odd or even amino acids
exposed to solvent. For each conformation, the hydrophobic contri-
bution of amino acid side chains to the binding energy was
summed up using the transfer energies from benzene to water,
amino acids exposed to solvent contributing positively, while those
in contact with the surface contributing negatively Eqs. (1) and (2).
In this way, one can determine the energetically most favorable
conformation of a given peptide adsorbed on a hydrophobic sur-
face. For a stable adsorption, this energy should be lower than
the one for the peptide in solution Eq. (3). For the LVEALYL peptide,
the most stable b-sheet conformation exposes the L–E–L–L amino
acids towards the solution, and the –V–A–Y– amino acids towards
the surface (interaction energy = 3.3 kcal mol1). For the LVAELYL
peptide, the most stable conformation exposes the –V–E–Y– amino
acids towards the solution, and the L–A–L–L amino acids towards
the surface (interaction energy = 16.3 kcal mol1). This justiﬁes
the better stability of the swapped peptide.
Two other peptides were studied, SVSASYS and LSASLSL, based
on the wild-type and the swapped peptides respectively, where the
amino acids supposed to face the surface were conserved and the
ones turned to the solvent replaced by serines (S). For both pep-
tides, the most stable conformation exposes hydrophilic S to the
solution and hydrophobic amino acids to the surface (interaction
energy = 8.2 kcal mol1 for LSASLSL and 1.1 kcal mol1, for
SVSAVYS). In the HI aggregation assay, the SVSASYS and the
LSASLSL peptides behaved similarly to their parent peptides (Ta-
ble 1), showing that the primary sequence exposed to the solvent
was not critical. The stronger effect of the LSASLSL peptide, com-
pared to the SVSASYS one, is again justiﬁed by its higher stability
on hydrophobic surfaces. The LSASLSL peptide also presents a
b-sheet rich conformation when adsorbed on hydrophobic surfaces
(Fig. 2C and Table 1S), and enhances HI binding on the surface
(Fig. 1).
To conﬁrm the importance of peptide conformation on the sur-
face, the (LKKLLKL)2 peptide, known to form a-helices on hydro-
phobic surfaces [15], was tested. This peptide indeed proved to
have completely different FTIR spectra, when compared to the
wildtype or swapped peptides (Fig. 2D, left and right panels). Its
transmission spectrum indicates that the (LKKLLKL)2 peptide
adopts b-sheet, random coil and a-helix conformations in solution
(60%, 7% and 33%, respectively; Table 1S). Strikingly, when
adsorbed on a hydrophobic surface, its ATR-FTIR signature
reveals typical peaks around 1641 and 1655 cm1, which indicates
that this peptide is predominantly in a-helical and random
conformation (Table 1S) upon adsorption. At substoichiometric
concentrations, (LKKLLKL)2 delays HI aggregation for up to 30 h
(Table 1). We therefore conclude that the conformation of the
adsorbed (LKKLLKL)2 peptide is not pro-aggregative but rather
stabilizes HI.
Furthermore a proline residue (P), was introduced to disrupt the
wildtype peptide secondary structure: LPEALYL, LVEPLYL and
SVSPSYS. None of these three peptides affect HI aggregationkinetics (Table 1), which consolidates the importance of peptide
b-sheet conformation on the surface.
Replacing the negatively charged glutamate residue (E) by a
threonine (T) in the wild type or swapped peptide had no effect
on the pro-aggregative property of the peptides, showing that elec-
trostatic interactions were not determinant (LVTALYL and LVATLYL
in Table 1). Again, the additional A to P mutation abolished the pro-
aggregative effect of these peptides (LVTPLYL and LVPTLYL in
Table 1).
Finally, we analyzed a peptide, ISISISI, exposing a series of three
Ser (S) to the solution and being adsorbed via four Ile (I) to the
hydrophobic surface. This peptide has a sequence that is similar
to the LKLKLKL peptide, known to form b-sheets on hydrophobic
surfaces [15–17], and has no common residues with LVEALYL.
The HI aggregation lagtime, obtained using this peptide in seeding
experiments, is 0.4 h. This peptide therefore also shows a pro-
aggregative effect on HI-surface aggregation and conﬁrms that
the primary sequence is not paramount.
4. Discussion
In this study, we show that the LVEALYL peptide, adsorbed on
hydrophobic surfaces at sub-stoichiometric concentrations, favors
HI binding and the formation of HI amyloidal ﬁbers. We previously
showed that HI adsorbed on hydrophobic surfaces exposes a mo-
tive containing the LVEALYL peptide, which is recognized by the
DnaK/DnaJ bacterial chaperones [6]. Combining these two observa-
tions indicates how HI amyloidal aggregates form on hydrophobic
surfaces. HI molecules adsorb and change their conformation,
exposing the LVEALYL peptide that allows further HI binding in a
b-sheet conformation. The conformational change induced on HI
directly adsorbed on the surface thus propagates to incoming HI
that binds to adsorbed HI. This mechanism is in accordance with
the insulin amyloid ﬁber model proposed by Ivanova et al. [11].
There is some similarity with the prion self-replication mechanism,
with soluble and adsorbed HI playing the role of PrPC and PrPSc,
respectively. An important difference is that HI amyloid aggregates
released into solution do not seed efﬁciently ﬁber growth.
This work conﬁrms the central role played by the LVEALYL pep-
tide, pointed out by Ivanova et al. [11]. We conﬁrm that the SLYQL-
ENY peptide, another HI segment putatively involved in the HI
amyloid structure, does not stimulate HI aggregation in contact
with hydrophobic material surfaces. This is reasonable since this
peptide is globally hydrophilic (DGsol = 12.3 kcal mol1) and
therefore not likely to adopt a b-sheet conformation on hydropho-
bic surfaces. Interestingly, introducing two mutations so that
hydrophobic amino acids are placed at even locations (LYQLEAY
peptide, DGconf1 = 13.9 kcal mol1) has a mild but signiﬁcant ef-
fect on HI aggregation kinetics (lag time = 3.4 h ± 0.1). Our study,
although limited to a subset of all possible peptides, strongly sug-
gests that the interaction of HI with the adsorbed peptide is not
highly sensitive to the primary structure, as long as the adsorbed
peptide provides a stable b-structure on the surface. Furthermore,
the effect of the short peptides on insulin aggregation is related to
their surface binding energy (minimum 5 kcal mol1) and re-
quires a b-sheet conformation (Fig. 3). The interaction with the
peptide-borne b-structure drives stable HI adsorption by triggering
an a to b transition in HI and consequent b-sheet formation be-
tween neighboring peptides and incoming HI molecules. This effect
is reminiscent of the effect of silver iodide crystals on super-cooled
H2O that induces the formation of ice crystals because of a match
between the crystal structures of b-AgI and ice. It is already known
that short peptides are able to inﬂuence full-length protein
amyloid aggregation at iso-stoichiometric concentrations [7–9].
Nevertheless, the impact of container surface chemistry is not sys-
tematically taken into account, despite the fact that hydrophobic
Fig. 2. Amide I band of the LVEALYL (A), LVAELYL (B) and LSASLSL (C) and (LKKLLKL)2 peptides in solution (left) and adsorbed on hydrophobic surfaces (right). Transmission
FTIR spectra were recorded with 8.6 lM peptides in deuterated buffer. For ATR-FTIR, peptides were introduced at 8.6 lM in the ﬂow chamber of a hexylmethyl-coated silicon
prism. After 30 min, the prism surface was washed with buffer and the infrared spectra were recorded. Thick line: amide I band after linear baseline correction. Thin lines:
decomposition of the amide I band into individual peaks.
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Fig. 3. Effect of different peptides on insulin kinetics. Aggregation kinetics of HI
(86 lM) alone or mixed with 8.6 lM peptide were determined. The nucleation rates
k (in the presence of peptide) and k0 (in the absence of peptide) were calculated as
the inverse of the lag time. For each peptide, the k/k0 ratio is plotted as a function of
the binding energy of the peptide on hydrophobic surfaces in b-strand conforma-
tion Eqs. (1) or (2). Circles: peptides without proline residue. Squares: peptides
containing one proline residue. Data are from Table 1. Lines are hand drawn.
1286 L. Nault et al. / FEBS Letters 587 (2013) 1281–1286interfaces are known to be able to induce the aggregation of differ-
ent proteins [5,18]. Here we show that peptides present in sub-
stoichiometric concentrations, adsorbed on hydrophobic surfaces
are able to accelerate or delay HI aggregation.
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